Advances in the Study of Endometrial Receptivity and Glucose Metabolism Mechanisms in Insulin Resistance
Endocrinology, Diabetes & Metabolism · 2026-07 · 9 (4)
DOI: 10.1002/edm2.70249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 11.06.2026. Verfasst von Si-Yan Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: Insulin Resistance, Endometrium, Glucose, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and technology project of Fujian Provincial Health Commission, the Youth Research Project of Fujian Provincial Health Commission, Fujian Province Science and Technology Innovation Joint Fund Project.
Abstract (Originalsprache)
Introduction
Insulin resistance (IR) is one of the important pathologic bases of polycystic ovary syndrome (PCOS) and an important factor contributing to infertility. In patients with PCOS, IR acts not only on insulin‐sensitive tissues, such as skeletal muscle, adipose tissue, and liver, but also on the ovaries and endometrium. Localised endometrial IR is closely associated with impaired endometrial receptivity, and proper glucose metabolism is a key factor for embryo implantation.
Methods
This paper describes the signalling pathways of endometrial glucose metabolism and the transcription factors regulated by endometrial glucose metabolism signalling pathways.
Results
The purpose of this paper is to explore the mechanism of endometrial glucose uptake in local IR and find key intersections in this mechanism. For example, Foxo1, as the intersection of the Insulin Receptor Substrate‐Phosphatidylinositol3‐kinase‐Protein Kinase B‐Glucose Transporters (IRS‐PI3K‐Akt‐GLUTs) pathway and the Cyclic Adenosine Monophosphate‐ Protein Kinase A‐ Calcium ion (cAMP‐PKA‐Ca 2+ ) pathway, and as an important biomarker for evaluating endometrial receptivity. It is of great significance for studying the improvement of endometrial receptivity.
Conclusions
This article summarises the therapeutic approaches targeting insulin resistance and the enhancement of endometrial receptivity based on the above pathways, so as to provide references and suggestions for future therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Group of Neuroendocrinology, Garvan Institute of Medical Research, Sydney, Australia.
- Centre of Neurological and Metabolic Research, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
ORCID-Profile: Ling-Tao Zheng, Jing Xu, Yan-Chuan Shi, Shu Lin
Förderung
- the Science and technology project of Fujian Provincial Health Commission
- the Youth Research Project of Fujian Provincial Health Commission
- Fujian Province Science and Technology Innovation Joint Fund Project
Zitieren
APA
Huang, S. Y., Chen, S. R., Chen, W. H., Zheng, L. T., Xu, J., Shi, Y. C., Lin, S., & Shi, Q. R. (2026). Advances in the Study of Endometrial Receptivity and Glucose Metabolism Mechanisms in Insulin Resistance. Endocrinology, Diabetes & Metabolism, 9(4). https://doi.org/10.1002/edm2.70249
Vancouver
Huang SY, Chen SR, Chen WH, Zheng LT, Xu J, Shi YC, et al. Advances in the Study of Endometrial Receptivity and Glucose Metabolism Mechanisms in Insulin Resistance. Endocrinology, Diabetes & Metabolism. 2026;9(4). doi:10.1002/edm2.70249
BibTeX
@article{Huang2026,
author = {Huang, Si-Yan and Chen, Shao-Rong and Chen, Wei-Hong and Zheng, Ling-Tao and Xu, Jing and Shi, Yan-Chuan and Lin, Shu and Shi, Qi-Rong},
title = {Advances in the Study of Endometrial Receptivity and Glucose Metabolism Mechanisms in Insulin Resistance},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {4},
doi = {10.1002/edm2.70249}
}
EUVIMED